跳至主要内容
临床试验/CTRI/2024/11/076937
CTRI/2024/11/076937已完成Unknown

Sugammadex versus Neostigmine - time to reversal of Rocuronium block in patients undergoing surgery under General Anaesthesia: A Randomized Controlled study

Preethi R1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年12月17日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Time taken from administering reversal agent (sugammadex or Neostigmine) to tracheal extubation

研究概览

简要总结

This study aims to identify time to reversal of rocuronium block in Neostigmine vs sugammadex (a newer reversal agent ) in Indian Population in patients undergoing surgery under General anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • ASA PS 1 and 2 Elective surgeries under general anaesthesia ( thyroid , ENT and breast surgeries).

排除标准

  • Emergency Surgery Pregnant patients Significant renal dysfunction, severe hepatic dysfunction, cardiac disease Anticipated difficult airway.

结局指标

主要结局

Time taken from administering reversal agent (sugammadex or Neostigmine) to tracheal extubation

时间窗: At baseline

次要结局

  • Compare the change in handgrip and Peak expiratory flow rate (PEFR) at 15min , 30 min and 60 min after reversal with Sugammadex or Neostigmine among patients undergoing general anaesthesia(15min, 30 min and 60 min)
  • Incidence of postoperative desaturation, upper airway obstruction, need for reintubation upto 1hour in PACU , 24 hours in ICU after reversal of Rocuronium induced neuromuscular blockade with Sugammadex and Neostigmine(24 hours)

研究者

发起方
Preethi R
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Preethi R

All India institute of Medical Sciences, Bibinagar

研究点 (1)

Loading locations...

相似试验